{
  "id": "cluster_3_doc3",
  "content": "Clinic report from Northwest Regional Sleep Center details successful implementation of 5mg melatonin regimen for a 42-year-old participant in cohort 12-2023. The patient showed reduced REM-related vocalizations within 14 days. Treatment approved under policy PL-8892 as alternative to pharmacotherapy. Follow-up scheduled after 90 days.",
  "metadata": {
    "format": "provider_report"
  }
}